Literature DB >> 18992710

NF-kappaB functions in osteoclasts.

N S Soysa1, N Alles.   

Abstract

NF-kappaB is a pleiotropic transcription factor, which regulates osteoclast formation, function, and survival. The finding that the deletion of both NF-kappaB p50 and p52 subunits resulted in osteopetrosis due to the absence of osteoclasts was followed by the observation that NF-kappaB is essential for RANK-expressing osteoclast precursors to differentiate into TRAP+ osteoclasts in response to RANKL and other osteoclastogenic cytokines. Thus, inhibitors of NF-kappaB should prevent osteoclast formation induced directly or indirectly by RANKL or TNF. In this mini review, we discuss the research findings that revealed essential roles of NF-kappaB signaling in osteoclasts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18992710     DOI: 10.1016/j.bbrc.2008.10.146

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  45 in total

1.  NF-κB in Aging and Disease.

Authors:  Jeremy S Tilstra; Cheryl L Clauson; Laura J Niedernhofer; Paul D Robbins
Journal:  Aging Dis       Date:  2011-12-02       Impact factor: 6.745

2.  Mice Deficient in NF-κB p50 and p52 or RANK Have Defective Growth Plate Formation and Post-natal Dwarfism.

Authors:  Lianping Xing; Di Chen; Brendan F Boyce
Journal:  Bone Res       Date:  2013-12-31       Impact factor: 13.567

3.  Andrographolide suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo.

Authors:  Z J Zhai; H W Li; G W Liu; X H Qu; B Tian; W Yan; Z Lin; T T Tang; A Qin; K R Dai
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

Review 4.  Zinc signal: a new player in osteobiology.

Authors:  Toshiyuki Fukada; Shintaro Hojyo; Tatsuya Furuichi
Journal:  J Bone Miner Metab       Date:  2012-11-27       Impact factor: 2.626

5.  Sophocarpine attenuates wear particle-induced implant loosening by inhibiting osteoclastogenesis and bone resorption via suppression of the NF-κB signalling pathway in a rat model.

Authors:  Chen-He Zhou; Zhong-Li Shi; Jia-Hong Meng; Bin Hu; Chen-Chen Zhao; Yu-Te Yang; Wei Yu; Ze-Xin Chen; Boon Chin Heng; Virginia-Jeni Akila Parkman; Shuai Jiang; Han-Xiao Zhu; Hao-Bo Wu; Wei-Liang Shen; Shi-Gui Yan
Journal:  Br J Pharmacol       Date:  2018-02-14       Impact factor: 8.739

6.  Activation of EPAC1/2 is essential for osteoclast formation by modulating NFκB nuclear translocation and actin cytoskeleton rearrangements.

Authors:  Aránzazu Mediero; Miguel Perez-Aso; Bruce N Cronstein
Journal:  FASEB J       Date:  2014-08-13       Impact factor: 5.191

Review 7.  NF-κB as a Therapeutic Target in Inflammatory-Associated Bone Diseases.

Authors:  T-H Lin; J Pajarinen; L Lu; A Nabeshima; L A Cordova; Z Yao; S B Goodman
Journal:  Adv Protein Chem Struct Biol       Date:  2016-12-09       Impact factor: 3.507

8.  Oxymatrine downregulates TLR4, TLR2, MyD88, and NF-kappaB and protects rat brains against focal ischemia.

Authors:  Hongguang Fan; Litao Li; Xiangjian Zhang; Ying Liu; Chenhui Yang; Yi Yang; Jing Yin
Journal:  Mediators Inflamm       Date:  2010-02-16       Impact factor: 4.711

9.  Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone.

Authors:  L Endo-Munoz; A Cumming; S Sommerville; I Dickinson; N A Saunders
Journal:  Br J Cancer       Date:  2010-06-15       Impact factor: 7.640

10.  Systemic administration of strontium or NBD peptide ameliorates early stage cartilage degradation of mouse mandibular condyles.

Authors:  Y-D Liu; H-X Yang; L-F Liao; K Jiao; H-Y Zhang; L Lu; M Zhang; J Zhang; J-J He; Y-P Wu; Di Chen; M-Q Wang
Journal:  Osteoarthritis Cartilage       Date:  2015-08-06       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.